TCTC Holdings’s Cytosorbents Corp CTSO Stock Holding History

TCTC Holdings’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,000	Closed	-$32.3K	–	454
2023 Q2	$32.3K	Hold	9,000	–	–	﹤0.01%	296
2023 Q1	$30.3K	Hold	9,000	–	–	﹤0.01%	319
2022 Q4	$13.9K	Hold	9,000	–	–	﹤0.01%	346
2022 Q3	$12K	Hold	9,000	–	–	﹤0.01%	343
2022 Q2	$20K	Hold	9,000	–	–	﹤0.01%	319
2022 Q1	$29K	Hold	9,000	–	–	﹤0.01%	306
2021 Q4	$38K	Hold	9,000	–	–	﹤0.01%	320
2021 Q3	$73K	Hold	9,000	–	–	﹤0.01%	266
2021 Q2	$68K	Hold	9,000	–	–	﹤0.01%	256
2021 Q1	$78K	Hold	9,000	–	–	﹤0.01%	243
2020 Q4	$72K	Hold	9,000	–	–	﹤0.01%	228
2020 Q3	$72K	Buy	+9,000	New	+$81.2K	﹤0.01%	221

Other funds holding CTSO

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JAMONY

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

TCTC Holdings's CTSO Position: Q3 2023 in Review

TCTC Holdings sold out of Cytosorbents Corp (CTSO) in Q3 2023, closing a stake of 9,000 shares — an estimated $32.3K sold.

TCTC Holdings first reported a position in CTSO in Q3 2020 and held it in 12 quarters. The position peaked at $78K in Q1 2021. 53 funds tracked by Wall St. Rank hold CTSO as of Q3 2023.

TCTC Holdings reported no remaining Cytosorbents Corp position as of Q3 2023 after selling out during the quarter.
TCTC Holdings sold 9,000 Cytosorbents Corp shares in Q3 2023, an estimated $32.3K.
TCTC Holdings first reported a position in Cytosorbents Corp in Q3 2020 and held it in 12 quarters.
TCTC Holdings's Cytosorbents Corp position peaked at $78K in Q1 2021.
53 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2023.

Based on TCTC Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.